Understanding Vaccines and Immune Defense

Nancy Liu-Sullivan holds a Ph.D. in Molecular and Cellular Pharmacology, served as a senior research scientist specializing in cancer genomics and drug discovery at Memorial Sloan Kettering Cancer Center (MSKCC) before joining the biology faculty at the City University of New York (CUNY) College of Staten Island (CSI), USA. In parallel to teaching and running a research lab that focuses on meta analysis of how differential expression of critical genes shape prognostics and patient overall survival in glioblastoma multiforme (GBM), melanoma, and breast cancer, Dr. Liu-Sullivan has published extensively on cancer studies for professionals as well as general audience. Selective books and essays include Understanding Cancer Immunotherapy: A Guide for Students, Patients, and Caregivers; Cancer’s Sweet Tooth; Nobel with a Sugar Twist; CRISPR: From Nature to Bench and Bedside; and Cell Therapy Coming of Age. Dr. Nancy Liu-Sullivan also published a co-authored paper with Dr. James D. Watson and team Sweden on the characterization of a promising new breast cancer drug HAMLET in 2011.

• ForewordAcronyms And AbbreviationsChronologyList of EntriesIntroductionA to Z EntriesBibliographyAbout the Author